Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Atypical symptoms in lupus can indicate different kidney issues.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

A multidisciplinary approach is key to delaying aging and preventing age-related diseases.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Rabbits with high wool production have more hair follicles, influenced by specific long noncoding RNAs.

Long noncoding RNAs help regulate hair follicle density in rabbits.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

New treatments offer hope for better managing hidradenitis suppurativa.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Researchers developed a 3D model of human hair follicle cells that can help understand hair growth and test new hair loss treatments.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.